Home » Newsletters » BioWorld

BioWorld

Oct. 10, 1991

View Archived Issues

AMEX TO TRADE SIX BIOTECH STOCKS

CELL GENESYS AT CENTER OF AIDS RESEARCH

AMERICAN BIOGENETIC TO REDEEM WARRANTS

NOVA GRANT TO ASSESS RECEPTOR BLOCKERS

MID-ATLANTIC VENTURE FAIR

ECOGEN FILES TO REGISTER SHARES WITH SEC

LIFE OBTAINS RIGHTS TO STAINING TECHNOLOGY

ALLIANCE SECONDARY RAISES $59 MILLION

ANALYST BOOSTS BIOGEN RATING

SOMATIX CLAIMS GENE THERAPY RIGHTS

RUSHED ddI APPROVAL MAY SET PRECEDENT

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...